MSD’s Keytruda receives DCGI approval for treating triple-negative breast cancer and renal cell carcinoma
Merck, known as MSD outside the U.S. and Canada, has recently earned the endorsement of the Drug Controller General of […]
RENAL-CELL-CARCINOMA
Cancer drug, when combined, boosts death risk
The cancer drug Avastin, also known as bevacizumab, is linked to a higher risk of death when combined with chemotherapy, said a study in the Journal of the American Medical Association.
